Aurobindo Pharma’s arm gets 3 observations from USFDA for Telangana API facility [Healthcare]
AI Summary1 min read
TL;DR
Aurobindo Pharma's subsidiary received 3 observations from the USFDA for its Telangana API facility, highlighting regulatory scrutiny in its global manufacturing operations.
Tags
Pharmaceuticals & DrugsHealthcareAurobindo PharmaUSFDAAPI facilityTelangana
Aurobindo Pharma is one of the leading vertically integrated formulations & API manufacturing companies in the world. It has a strong R&D focus and has a multi-product portfolio with manufacturing facilities in several countries. The company operates diversified businesses, structured to deliver targeted healthcare solutions across geographies and therapeutic areas. Its core operations are built on strong, integrated capabilities, encompassing both APIs and finished products. The company is one of the leading API manufacturers, with expertise in process chemistry and having the advantage of large-scale production. It is recognised globally for high-quality, reliable and cost-effective supplies. Its API business caters to both internal needs and external client demand across multiple therapeutic areas, driving profitability and sustaining the growth of its formulations area.